Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Early Pipeline Case Study

- PMLiVE

The benefits of uniting in a divergent environment

Thoughts from Emma Statham, chief executive, Four Health

Four Agency Worldwide

- PMLiVE

Encouraging signs in biomarker R&D

The cancer immunotherapy firms ramping-up biomarker R&D

- PMLiVE

J&J puts pressure on rivals with new Erleada okay in prostate cancer

FDA previously granted priority review in this indication

Pharma exhibition stand design with added value

Everyone wants an engaging trade show booth. But, to achieve this, it’s essential to think beyond design and construction.  With over 30 years’ experience in exhibition stand design, we use all...

Apex Events and Exhibitions

- PMLiVE

bluebird bio reveals further encouraging data for CALD gene therapy

Study shows continued benefit in treatment of rare disease

- PMLiVE

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

- PMLiVE

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

Ranitidine medicines found to contain cancer-causing substance

Programmatic methodology and why you should be using it

What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director

Four Agency Worldwide

- PMLiVE

When it’s OK to not be OK: Bedrock breaks down mental health stigma

As part of Bedrock’s Wellbeing Programme, Bedrock paired up with Simpila to talk about mental health challenges and open up about the pressures we all face, both in and out...

Bedrock Healthcare Communications

Roche - Basel

Roche wins FDA breakthrough for Gazyva in lupus nephritis

Drug originally approved as a lymphoma treatment

- PMLiVE

Zenopa delivers Communiqué prizes to winners

Publicis Resolute's Georgina Chan, MGP's Peter Sayer and Celgene's Sara Jones win the prizes

Detecting Alzheimer’s ahead of a cure

A focus on promising new research

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links